Announcements - Search results

Search results: Company announcements for
IMPEDIMED LIMITED (IPD)
Released between 01/01/2017 and 31/12/2017

Didn't find the announcement you were after? Search again.

Announcements released as IPD
Date Price sens. Headline
29/12/2017
9:25 AM
  PREVENT Trial Enrolment Reaches 1,100 Patients
2 pages 55.0KB
28/12/2017
4:58 PM
  Notification under section 708A(5)(e)
2 pages 64.1KB
28/12/2017
4:55 PM
  Appendix 3B
12 pages 134.5KB
27/12/2017
8:27 AM
asterix US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO
2 pages 64.7KB
18/12/2017
4:45 PM
  Notification under section 708A(5)(e)
2 pages 39.7KB
18/12/2017
4:45 PM
  Appendix 3B
12 pages 130.7KB
18/12/2017
3:12 PM
  Link Market Services - Change of Brisbane Address
3 pages 159.9KB
12/12/2017
2:49 PM
  Notification under section 708A(5)(e)
2 pages 39.6KB
12/12/2017
2:49 PM
  Appendix 3B
12 pages 130.8KB
11/12/2017
11:15 AM
  Change of Director's Interest Notice
4 pages 105.1KB
11/12/2017
8:26 AM
  Notification under section 708A(5)(e)
2 pages 39.7KB
11/12/2017
8:25 AM
  Appendix 3B
12 pages 131.4KB
06/12/2017
1:41 PM
  Notification under section 708A(5)(e)
2 pages 39.5KB
06/12/2017
1:40 PM
  Appendix 3B
12 pages 130.4KB
01/12/2017
12:03 PM
  L-Dex Abstracts Released - Breast Cancer Symposium
2 pages 61.4KB
16/11/2017
10:20 AM
  Final Director's Interest Notice
2 pages 68.9KB
16/11/2017
10:20 AM
  Initial Director's Interest Notice
2 pages 53.7KB
16/11/2017
10:19 AM
  Change of Director's Interest Notice
3 pages 63.5KB
16/11/2017
10:18 AM
  Appendix 3B
13 pages 138.3KB
15/11/2017
5:11 PM
  Change in substantial holding
3 pages 448.9KB
15/11/2017
11:39 AM
  Results of Meeting
1 page 59.8KB
15/11/2017
9:07 AM
  Chairman's Address
3 pages 60.5KB
09/11/2017
8:27 AM
  Annual General Meeting Presentation
28 pages 10.0MB
08/11/2017
10:56 AM
asterix L-Dex Abstracts to be Presented at Breast Cancer Symposium
2 pages 196.4KB
06/11/2017
8:35 AM
asterix 2018 Reimbursement Amounts Published by CMS
1 page 42.0KB
31/10/2017
8:58 AM
asterix Multi-year Exclusive Distribution Agreement Signed
2 pages 88.2KB
27/10/2017
7:54 PM
  Change in substantial holding
4 pages 234.4KB
27/10/2017
5:06 PM
  Change in substantial holding
5 pages 131.6KB
25/10/2017
8:24 AM
asterix Appendix 4C - Quarter ended 30 September 2017
8 pages 518.2KB
24/10/2017
9:57 AM
  ImpediMed Quarterly Results & Investor Conference Call
1 page 88.3KB
23/10/2017
10:34 AM
asterix Shipments of SOZO with L-Dex Commence in the US
2 pages 84.9KB
23/10/2017
8:25 AM
asterix Publication of Major Study in Leading Medical Journal
2 pages 97.6KB
16/10/2017
1:27 PM
  Notice of Annual General Meeting & Proxy Form
21 pages 407.2KB
16/10/2017
9:26 AM
  ImpediMed announces changes to Board of Directors
2 pages 85.7KB
15/09/2017
2:03 PM
  Notification under section 708A(5)(e)
2 pages 80.7KB
15/09/2017
2:02 PM
  Appendix 3B
12 pages 197.5KB
30/08/2017
1:19 PM
  Change of Director's Interest Notice
2 pages 101.5KB
24/08/2017
11:01 AM
asterix New Study Reports Superior Clinical Outcomes Utilising L-Dex
2 pages 150.2KB
23/08/2017
8:55 AM
  Appendix 4G and Corporate Governance Statement
29 pages 854.5KB
23/08/2017
8:54 AM
  2017 Annual Report
142 pages 9.4MB
23/08/2017
8:52 AM
asterix Appendix 4E - year ended 30 June 2017
4 pages 215.3KB
21/08/2017
11:00 AM
asterix Heart Failure 510(k) Application for SOZO Submitted to FDA
2 pages 80.6KB
14/08/2017
9:47 AM
asterix US FDA 510(k) Clearance Issued for SOZO with L-Dex
1 page 76.5KB
08/08/2017
12:17 PM
asterix First patient enrolled in SOZO CHF Trial at Scripps Health
2 pages 82.1KB
24/07/2017
8:50 AM
  Investor Presentation
22 pages 2.5MB
24/07/2017
8:38 AM
asterix Appendix 4C - Quarter ended 30 June 2017
8 pages 1.2MB
21/07/2017
3:18 PM
  ImpediMed Quarterly Results and Investor Conference Call
1 page 88.3KB
17/07/2017
9:04 AM
asterix IPD Submits FDA 510(k) Application for SOZO for Lymphoedema
2 pages 78.4KB
10/07/2017
5:39 PM
  Ceasing to be a substantial holder from MQG
18 pages 831.8KB
04/07/2017
10:54 AM
asterix L-Dex Recommended in Clinical Practice Guidelines
2 pages 82.5KB
30/06/2017
7:41 AM
  Notification under section 708A(5)(e)
2 pages 82.6KB
30/06/2017
7:40 AM
  Appendix 3B
12 pages 192.3KB
29/06/2017
5:54 PM
  Becoming a substantial holder from MQG
19 pages 866.3KB
29/06/2017
9:09 AM
  ImpediMed Commences Commercial Sales of SOZO
2 pages 77.2KB
21/06/2017
2:48 PM
  Notification under section 708A(5)(e)
2 pages 80.7KB
21/06/2017
2:46 PM
  Appendix 3B
12 pages 185.9KB
21/06/2017
8:26 AM
asterix SOZO obtains CE Mark for Heart Failure Patient Monitoring
2 pages 106.2KB
14/06/2017
10:25 AM
asterix Macquarie University Commences Lymphoedema Study Using Sozo
1 page 75.8KB
13/06/2017
10:57 AM
  Change of Director's Interest Notice
2 pages 100.1KB
18/05/2017
8:29 AM
asterix L-Dex Study - Significant Reduction in Clinical Lymphoedema
2 pages 97.5KB
01/05/2017
8:16 AM
  Appendix 3B
12 pages 182.6KB
27/04/2017
8:21 AM
  Change in substantial holding
9 pages 365.8KB
26/04/2017
8:25 AM
asterix March 2017 Quarter Results & Investor Conference Call
2 pages 99.8KB
26/04/2017
8:24 AM
asterix Appendix 4C - Quarter Ended 31 March 2017
5 pages 1.1MB
24/04/2017
8:33 AM
  Impedimed Quarterly Results and Investor Conference Call
1 page 80.2KB
24/04/2017
8:33 AM
asterix SOZO Shipped to Vanderbilt to Commence At-Home Study
2 pages 80.0KB
10/04/2017
12:28 PM
  Initial Director's Interest Notice
2 pages 87.3KB
10/04/2017
8:26 AM
  Board of Directors Appointment
2 pages 77.9KB
27/03/2017
1:59 PM
  Investor Presentation
24 pages 1.3MB
24/03/2017
2:36 PM
  Initial Director's Interest Notice
2 pages 98.7KB
23/03/2017
5:20 PM
  Notification under section 708A(5)(e)
2 pages 80.9KB
23/03/2017
5:20 PM
  Appendix 3B
12 pages 196.3KB
23/03/2017
3:36 PM
  initial Director's Interest Notice
2 pages 87.3KB
20/03/2017
9:00 AM
  Appointment of Non-Executive Directors
2 pages 85.8KB
13/03/2017
2:03 PM
  Notification under section 708A(5)(e)
2 pages 81.1KB
13/03/2017
2:03 PM
  Appendix 3B
12 pages 196.3KB
07/03/2017
8:26 AM
asterix Placement of First SOZO Unit at Scripps Health
2 pages 88.8KB
07/03/2017
8:26 AM
  Appendix 3B
12 pages 198.4KB
24/02/2017
9:04 AM
  Press Release Half-Year Results
2 pages 99.6KB
24/02/2017
8:47 AM
asterix Appendix 4D and Financial Report 31 December 2016
34 pages 793.6KB
06/02/2017
8:33 AM
  Final Director's Interest Notice
2 pages 99.0KB
02/02/2017
5:21 PM
  Change in substantial holding
4 pages 126.0KB
31/01/2017
8:25 AM
asterix Appendix 4C - Quarter Ended 31 December 2016
8 pages 1.2MB
30/01/2017
8:24 AM
  ImpediMed Quarterly Results & Investor Conference Call
2 pages 78.4KB
17/01/2017
10:02 AM
  Director Retirement
1 page 66.7KB
16/01/2017
8:27 AM
  Appendix 3B
12 pages 182.9KB

Useful Information

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.